American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 491-503 , March 2008

Osmotic Nephrosis: Acute Kidney Injury With Accumulation of Proximal Tubular Lysosomes Due to Administration of Exogenous Solutes

  • Michael Dickenmann, MD

      Affiliations

    • Clinic for Transplantation Immunology and Nephrology, University Hospital, Basel, Switzerland
    • ,
  • Tobias Oettl, MD

      Affiliations

    • Department of Internal Medicine, University Hospital, Basel, Switzerland
    • Corresponding Author InformationAddress correspondence to Tobias Oettl, MD, Department of Internal Medicine, University Hospital, CH-4031 Basel, Switzerland.
    • ,
  • Michael J. Mihatsch, MD

      Affiliations

    • Institute for Pathology, University Hospital, Basel, Switzerland.

Received 16 June 2007 ,Accepted 22 October 2007.

References 

  1. Allen AC. Diseases of the tubules. In: Grune ,  Stratton I editor. The Kidney: Medical and Surgical Diseases. New York, NY: Grune & Stratton; 1951;p. 207–298
  2. Janssen CW. Osmotic nephrosis (A clinical and experimental investigation). Acta Chir Scand. 1968;134:481–487
  3. Blullock LT, Gregersen ML, Kinney R. The use of hypertonic sucrose solution intravenously to reduce cerebrospinal fluid pressure without a secondary rise. Am J Physiol. 1935;112:82–86
  4. Massermann JH. Effects of the intravenous administration of hypertonic solution of sucrose with special reference to cerebrospinal fluid pressure. Bull Johns Hopkins Hosp. 1935;57:12–17
  5. Helmholz HF. Renal changes in the rabbit resulting from intravenous injection of hypertonic solution of sucrose. J Pediatr. 1933;3:144–157
  6. Anderson AA, Bethea WR. Renal lesions following administration of hypertonic solutions of sucrose. J Am Med Assoc. 1940;114:1983–1987
  7. Zollinger HU. Niere und ableitende Harnwege. New York, NY: Springer Verlag; 1966;
  8. Maunsbach AB, Madden SC, Latta H. Light and electron microscopic changes in proximal tubules of rats after administration of glucose, mannitol, sucrose, or dextran. Lab Invest. 1962;11:421–432
  9. Zollinger HU, Mihatsch MJ. Renal Pathology in Biopsy. Berlin, Germany: Springer Verlag; 1978;
  10. Trump BF, Janigan DT. The pathogenesis of cytologic vacuolization in sucrose nephrosis (An electron microscopic and histochemical study). Lab Invest. 1962;11:395–411
  11. Rohr HP, Zollinger HU. [The so-called “sugar storing kidney” with special consideration of electron microscopic autoradiographic studies with C-14 saccharose]. Virchows Arch Pathol Anat Physiol Klin Med. 1966;341:115–122
  12. Cornu P, Caulin C, Marsan C, et al. [Osmotic nephropathy (Specific iatrogenic disease or nonspecific tubular reaction?). ] Sem Hop. 1973;49:1429–1430
  13. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore). 1990;69:153–159
  14. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc. 1988;20:759–771
  15. Fillastre JP, Mignon F, Sraer JD, et al. [Acute reversible renal insufficiency after prolonged treatment with dextran]. Presse Med. 1967;75:2535–2538
  16. Lampe WT. Interstitial nephritis: Reversibility of osmotic changes due to mannitol proved by biopsy. Angiology. 1965;16:281–287
  17. Ryffel B, Foxwell BM, Gee A, et al. Cyclosporine—Relationship of side effects to mode of action. Transplantation. 1988;46(suppl 2):S90–S96
  18. Hess R, Bartels MJ, Pottenger LH. Ethylene glycol: An estimate of tolerable levels of exposure based on a review of animal and human data. Arch Toxicol. 2004;78:671–680
  19. Schwartz SL, Johnson CB. Pinocytosis as the cause of sucrose nephrosis. Nephron. 1971;8:246–254
  20. Chacko B, John GT, Balakrishnan N, et al. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy. Ren Fail. 2006;28:193–195
  21. Kwan TH, Tong MK, Siu YP, et al. Acute renal failure related to intravenous immunoglobulin infusion in an elderly woman. Hong Kong Med J. 2005;11:45–49
  22. Diomi P, Ericsson JL, Matheson NA. Effects of dextran 40 on urine flow and composition during renal hypoperfusion in dogs with osmotic nephrosis. Ann Surg. 1970;172:813–824
  23. Engberg A, Ericsson JL. Effects of dextran 40 on proximal renal tubule (Electron microscopic and cytochemical studies in the mouse). Acta Chir Scand. 1969;135:263–274
  24. Engberg A. Effects of dextran 40 on the proximal renal tubule (Studies on transfer maxima of glucose and hippuran in the rat). Acta Chir Scand. 1976;142:172–180
  25. Christensen EI, Maunsbach AB. Effects of dextran on lysosomal ultrastructure and protein digestion in renal proximal tubule. Kidney Int. 1979;16:301–311
  26. Christensen EI, Maunsbach AB. Dextran is resistant to lysosomal digestion in kidney tubules. Virchows Arch B Cell Pathol Incl Mol Pathol. 1981;37:49–59
  27. Tervahartiala P, Kivisaari L, Kivisaari R, et al. Contrast media-induced renal tubular vacuolization (A light and electron microscopic study on rat kidneys). Invest Radiol. 1991;26:882–887
  28. Tervahartiala P. Contrast media-induced renal tubular vacuolization after dehydration (A light and electron microscopic study in rats). Invest Radiol. 1992;27:114–118
  29. Nordby A, Tvedt KE, Halgunset J, et al. Intracellular penetration and accumulation of radiographic contrast media in the rat kidney. Scanning Microsc. 1990;4:651–664
  30. Brezis M, Heyman SN, Epstein FH. Determinants of intrarenal oxygenation (II. Hemodynamic effects). Am J Physiol. 1994;267:F1063–F1068
  31. Brezis M, Agmon Y, Epstein FH. Determinants of intrarenal oxygenation (I. Effects of diuretics). Am J Physiol. 1994;267:F1059–F1062
  32. Heyman SN, Brezis M, Epstein FH, et al. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int. 1991;40:632–642
  33. Palm F, Cederberg J, Hansell P, et al. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia. 2003;46:1153–1160
  34. Garvin PJ, Gargan B. Toxicity: Subacute toxicology of intravenous mannitol. In:  Mazze RI,  Barry KG editor. Abstracts of the Symposium on the Clinical and Experimental Use of Mannitol. Washington DC: Walter Reed Army Institute of Research, Walter Reed Army Medical Center; 1962;
  35. Hofmeister R, Bhargava AS, Gunzel P. The use of urinary N-acetyl-beta-d-glucosaminidase (NAG) for the detection of contrast-media-induced ‘osmotic nephrosis’ in rats. Toxicol Lett. 1990;50:9–15
  36. Laurent G, Kishore BK, Tulkens PM. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol. 1990;40:2383–2392
  37. Merski JA, Meyers MC. Light- and electron-microscopic evaluation of renal tubular cell vacuolation induced by administration of nitrilotriacetate or sucrose. Food Chem Toxicol. 1985;23:923–930
  38. Olier B, Morin JP, Grancher G, et al. Regenerating tubular cell process in rat kidney: Influence of gentamicin treatment. Int J Tissue React. 1987;9:241–250
  39. Tervahartiala P, Kivisaari L, Kivisaari R, et al. Letter. Invest Radiol. 1993;28:188–190
  40. Diomi P, Engberg A, Ericsson JL, et al. Studies on renal tubular morphology, toxicity and function after large doses of dextran 40 in the dog. Acta Chir Scand. 1969;135:345–355
  41. Morard JC. [Experimental contribution to the study of osmotic nephrosis; Excess glucose; Excess water; Acute hyponatremia]. Helv Med Acta. 1956;23:215–239
  42. Moreau JF, Droz D, Sabto J, et al. Osmotic nephrosis induced by water-soluble triiodinated contrast media in man (A retrospective study of 47 cases). Radiology. 1975;115:329–336
  43. Moreau JF, Noel LH, Droz D. Proximal renal tubular vacuolization induced by iodinated contrast media, or so-called “osmotic nephrosis”. Invest Radiol. 1993;28:187–190
  44. Food and Drug Administration (FDA): Renal insufficiency and failure associated with immune globulin intravenous therapy—United States, 1985-1998. MMWR Morbid Mortal Wkly Rep. 1999;48:518–521z
  45. Gras V, Andrejak M, Decocq G. Acute renal failure associated with intravenous immunoglobulins. Pharmacoepidemiol Drug Saf. 1999;8(suppl 1):S73–S78
  46. Barton JC, Herrera GA, Galla JH, et al. Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med. 1987;82:624–629
  47. Ahsan N, Palmer BF, Wheeler D, et al. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med. 1994;154:1985–1987
  48. Cantu TG, Hoehn-Saric EW, Burgess KM, et al. Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis. 1995;25:228–234
  49. Hansen-Schmidt S, Silomon J, Keller F. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kidney Dis. 1996;28:451–453
  50. Kobosko J, Nicol P. Renal toxicity of intravenous immunoglobulin. Clin Nephrol. 1992;37:216–217
  51. Phillips AO. Renal failure and intravenous immunoglobulin. Clin Nephrol. 1992;37:217
  52. Rault R, Piraino B, Johnston JR, et al. Pulmonary and renal toxicity of intravenous immunoglobulin. Clin Nephrol. 1991;36:83–86
  53. Tan E, Hajinazarian M, Bay W, et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol. 1993;50:137–139
  54. Tsinalis D, Dickenmann M, Brunner F, et al. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. Am J Kidney Dis. 2002;40:667–670
  55. Ahsan N, Wiegand LA, Abendroth CS, et al. Acute renal failure following immunoglobulin therapy. Am J Nephrol. 1996;16:532–536
  56. Khalil M, Shin HJ, Tan A, et al. Macrophagelike vacuolated renal tubular cells in the urine of a male with osmotic nephrosis associated with intravenous immunoglobulin therapy (A case report). Acta Cytol. 2000;44:86–90
  57. Winward DB, Brophy MT. Acute renal failure after administration of intravenous immunoglobulin: Review of the literature and case report. Pharmacotherapy. 1995;15:765–772
  58. Brannagan TH, Nagle KJ, Lange DJ, et al. Complications of intravenous immune globulin treatment in neurologic disease. Neurology. 1996;47:674–677
  59. Sati HI, Ahya R, Watson HG. Incidence and associations of acute renal failure complicating high-dose intravenous immunoglobulin therapy. Br J Haematol. 2001;113:556–557
  60. Katz U, Achiron A, Sherer Y, et al. Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev. 2007;6:257–259
  61. Taggart WR, Thibodeau GA, Swanson RN. Mannitol induced renal alterations in rabbits. S D J Med. 1968;21:30–34
  62. Stuart FP, Torres E, Fletcher R, et al. Effects of single, repeated and massive mannitol infusion in the dog: Structural and functional changes in kidney and brain. Ann Surg. 1970;172:190–204
  63. Plouvier B, Baclet JL, de Coninck P. [A nephrotoxic combination: Mannitol and furosemide]. Nouv Presse Med. 1981;10:1744–1745
  64. Gadallah MF, Lynn M, Work J. Case report: Mannitol nephrotoxicity syndrome: Role of hemodialysis and postulate of mechanisms. Am J Med Sci. 1995;309:219–222
  65. Brunner FP, Hermle M, Mihatsch MJ, et al. Mannitol potentiates cyclosporine nephrotoxicity. Clin Nephrol. 1986;25(suppl 1):S130–S136
  66. Biesenbach G, Zazgornik J, Kaiser W, et al. Severe tubulopathy and kidney graft rupture after coadministration of mannitol and ciclosporin. Nephron. 1992;62:93–96
  67. Visweswaran P, Massin EK, DuBose TD. Mannitol-induced acute renal failure. J Am Soc Nephrol. 1997;8:1028–1033
  68. Lin SL, Hung KY, Wu FL, et al. Mannitol-induced acute renal failure. Nephrol Dial Transplant. 1995;10:120–122
  69. Perez-Perez AJ, Pazos B, Sobrado J, et al. Acute renal failure following massive mannitol infusion. Am J Nephrol. 2002;22:573–575
  70. Better OS, Rubinstein I, Winaver JM, et al. Mannitol therapy revisited (1940-1997). Kidney Int. 1997;52:886–894
  71. Rabetoy GM, Fredericks MR, Hostettler CF. Where the kidney is concerned, how much mannitol is too much?. Ann Pharmacother. 1993;27:25–28
  72. Doi K, Ogawa N, Suzuki E, et al. Mannitol-induced acute renal failure. Am J Med. 2003;115:593–594
  73. Rello J, Triginer C, Sanchez JM, et al. Acute renal failure following massive mannitol infusion. Nephron. 1989;53:377–378
  74. Horgan KJ, Ottaviano YL, Watson AJ. Acute renal failure due to mannitol intoxication. Am J Nephrol. 1989;9:106–109
  75. Goldwasser P, Fotino S. Acute renal failure following massive mannitol infusion (Appropriate response of tubuloglomerular feedback?). Arch Intern Med. 1984;144:2214–2216
  76. Weaver A, Sica DA. Mannitol-induced acute renal failure. Nephron. 1987;45:233–235
  77. Du J, Cao J, Zhao H. [Mannital induced acute renal failure]. Zhonghua Wai Ke Za Zhi. 1996;34:436–437
  78. van Hengel P, Nikken JJ, de Jong GM, et al. Mannitol-induced acute renal failure. Neth J Med. 1997;50:21–24
  79. Suzuki K, Miki M, Ono Y, et al. [Acute renal failure following mannitol infusion]. Hinyokika Kiyo. 1993;39:721–724
  80. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med. 1987;317:150–153
  81. Arturson G, Wallenius G. The renal clearance of dextran of different molecular sizes in normal humans. Scand J Clin Lab Invest. 1964;16:81–86
  82. Birke G, Liljedahl SO. [Kidney injuries in extensive burns with regard to treatment with rheomacrodex]. Schweiz Med Wochenschr. 1966;96:525–533
  83. Mailloux L, Swartz CD, Capizzi R, et al. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med. 1967;277:1113–1118
  84. Morgan T, Little JM. Renal failure and low-molecular-weight dextran. Br Med J. 1967;1:635
  85. Matheson NA, Diomi P. Renal failure after the administration of dextran 40. Surg Gynecol Obstet. 1970;131:661–668
  86. Alvarez GH, Oliva AH, Lopez DN, et al. [Acute renal failure caused by dextran of low molecular weight]. Rev Clin Esp. 1970;116:169–172
  87. Burgos-Calderon R, Figueroa JE. Acute oliguric renal failure associated with low-molecular-weight dextran. Bol Asoc Med P R. 1972;64:1–4
  88. Feest TG. Low molecular weight dextran: A continuing cause of acute renal failure. Br Med J. 1976;2:1300
  89. Schwarz J, Ihle B, Dowling J. Acute renal failure induced by low molecular weight dextran. Aust N Z J Med. 1984;14:688–689
  90. Zwaveling JH, Meulenbelt J, van Xanten NH, et al. Renal failure associated with the use of dextran-40. Neth J Med. 1989;35:321–326
  91. Druml W, Polzleitner D, Laggner AN, et al. Dextran-40, acute renal failure, and elevated plasma oncotic pressure. N Engl J Med. 1988;318:252–253
  92. Kurnik BR, Singer F, Groh WC. Case report: Dextran-induced acute anuric renal failure. Am J Med Sci. 1991;302:28–30
  93. Hardin CK, Kirk WC, Pederson WC. Osmotic complications of low-molecular-weight dextran therapy in free flap surgery. Microsurgery. 1992;13:36–38
  94. Matsushima H, Yonemura K, Nakamura T, et al. [Case of acute kidney failure induced low-molecular weight dextran effectively treated by plasma exchange]. Nippon Naika Gakkai Zasshi. 1994;83:294–295
  95. Morgan TO, Little JM, Evans WA. Renal failure associated with low-molecular-weight dextran infusion. Br Med J. 1966;2:737–739
  96. Biesenbach G, Kaiser W, Zazgornik J. Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage III or IV. Ren Fail. 1997;19:69–75
  97. Frey L, Messmer K. Acute oligoanuric renal failure in dextran 40 treated patients. Ren Fail. 1998;20:543–545
  98. Brooks D, Okeefe P, Buncke HJ. Dextran-induced acute renal failure after microvascular muscle transplantation. Plast Reconstr Surg. 2001;108:2057–2060
  99. Kato A, Yonemura K, Matsushima H, et al. Complication of oliguric acute renal failure in patients treated with low-molecular weight dextran. Ren Fail. 2001;23:679–684
  100. Vos SC, Hage JJ, Woerdeman LA, et al. Acute renal failure during dextran-40 antithrombotic prophylaxis: Report of two microsurgical cases. Ann Plast Surg. 2002;48:193–196
  101. Chinitz JL, Kim KE, Onesti G, et al. Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med. 1971;77:76–87
  102. Manning RD. Effects of hypoproteinemia on renal hemodynamics, arterial pressure, and fluid volume. Am J Physiol. 1987;252:F91–F98
  103. Goldenberg M, Crane D, Popper H. Effect of intravenous administration of dextran, a macromolecular carbohydrate, in animals. Am J Clin Pathol. 1947;17:939–948
  104. Ishikawa E. [Experimental study of drug-induced acute renal failure. Recovery after renal impairment caused by the administration of low molecular weight dextran and kanamycin in water-deprived rats]. Hinyokika Kiyo. 1988;34:215–224
  105. Van Den Berg CJ, Pineda AA. Plasma exchange in the treatment of acute renal failure due to low molecular-weight dextran. Mayo Clin Proc. 1980;55:387–389
  106. Ferraboli R, Malheiro PS, Abdulkader RC, et al. Anuric acute renal failure caused by dextran 40 administration. Ren Fail. 1997;19:303–306
  107. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491–499
  108. Sandler CM. Contrast-agent-induced acute renal dysfunction—Is iodixanol the answer?. N Engl J Med. 2003;348:551–553
  109. Pendergrass EP, Chamberlain GW, Godfrey EW. A survey of death and unfavorable sequelae following the administration of contrast media. Am J Radiol. 1942;48:741–762
  110. Rudnick MR, Berns JS, Cohen RM, et al. Nephrotoxic risks of renal angiography: Contrast media-associated nephrotoxicity and atheroembolism—A critical review. Am J Kidney Dis. 1994;24:713–727
  111. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol. 1994;5:125–137
  112. Yoshioka T, Fogo A, Beckman JK. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int. 1992;41:1008–1015
  113. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans: Role of renal vasoconstriction. Kidney Int. 1992;41:1408–1415
  114. Kramer BK, Kammerl M, Schweda F, et al. A primer in radiocontrast-induced nephropathy. Nephrol Dial Transplant. 1999;14:2830–2834
  115. Niu G. [Experimental histopathological studies of renal lesions induced by high- or low-osmolality contrast media]. Nippon Ika Daigaku Zasshi. 1993;60:390–405
  116. Battenfeld R, Khater Ae, Drommer W, et al. Ioxaglate-induced light and electron microscopic alterations in the renal proximal tubular epithelium of rats. Invest Radiol. 1991;26:35–39
  117. Tervahartiala P, Kivisaari L, Kivisaari R, et al. Contrast media-induced renal tubular vacuolization (A light and electron microscopic study on rat kidneys). Invest Radiol. 1991;26:882–887
  118. Tervahartiala P, Kivisaari R, Virtanen I. Contrast media-induced renal morphologic changes in rats with acute edematous pancreatitis. Invest Radiol. 1992;27:520–524
  119. Tervahartiala P, Kivisaari L, Kivisaari R, et al. Contrast media-induced renal morphologic lesions during experimental hemorrhagic necrotizing pancreatitis. Invest Radiol. 1992;27:1064–1068
  120. Tervahartiala P. Contrast media-induced renal tubular vacuolization after dehydration (A light and electron microscopic study in rats). Invest Radiol. 1992;27:114–118
  121. Tervahartiala P, Kivisaari L, Kivisaari R, et al. Contrast media-induced renal morphologic lesions in diabetic rats. Acta Radiol. 1993;34:220–225
  122. Golman K, Almen T. Contrast media-induced nephrotoxicity (Survey and present state). Invest Radiol. 1985;20(suppl 1):S92–S97
  123. Heyman SN, Brezis M, Reubinoff CA, et al. Acute renal failure with selective medullary injury in the rat. J Clin Invest. 1988;82:401–412
  124. Rees JA, Old SL, Rowlands PC. An ultrastructural histochemistry and light microscopy study of the early development of renal proximal tubular vacuolation after a single administration of the contrast enhancement medium “Iotrolan”. Toxicol Pathol. 1997;25:158–164
  125. Gruskin AB, Oetliker OH, Wolfish NM, et al. Effects of angiography on renal function and histology in infants and piglets. J Pediatr. 1970;76:41–48
  126. Kleinknecht D, Jungers P, Michel JR, et al. [Complications of osmotic nephrosis after perfusion urography in renal insufficiency]. Ann Med Interne (Paris). 1971;122:1167–1171
  127. Kleinknecht D, Landais P, Goldfarb B. [Acute renal failure associated with drugs or iodinated contrast media. Results of a cooperative multicentric study by the Nephrology Society]. Nephrologie. 1986;7:41–46
  128. Moreau JF, Droz D, Noel LH, et al. Tubular nephrotoxicity of water-soluble iodinated contrast media. Invest Radiol. 1980;15(suppl 6):S54–S60
  129. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure: Is a change of clinical practice indicated?. Drug Saf. 2002;25:837–846
  130. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet. 2001;358:581–583
  131. De Labarthe A, Jacobs F, Blot F, et al. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med. 2001;111:417–418
  132. Peron S, Mouthon L, Guettier C, et al. Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol. 2001;55:408–411
  133. Dickenmann MJ, Filipovic M, Schneider MC, et al. Hydroxyethylstarch-associated transient acute renal failure after epidural anaesthesia for labour analgesia and Caesarean section. Nephrol Dial Transplant. 1998;13:2706
  134. Godet G. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet. 2001;358:581
  135. Gosling P, Rittoo D, Manji M, et al. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet. 2001;358:581
  136. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: A multicentre randomised study. Lancet. 2001;357:911–916
  137. Waldhausen P, Kiesewetter H, Leipnitz G, et al. [Hydroxyethyl starch-induced transient renal failure in preexisting glomerular damage]. Acta Med Austriaca. 1991;18(suppl 1):S52–S55
  138. Haskell LP, Tannenberg AM. Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration. N Y State J Med. 1988;88:387–388
  139. Vogt NH, Bothner U, Lerch G, et al. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: Plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg. 1996;83:262–268
  140. Ebcioglu Z, Cohen DJ, Crew RJ, et al. Osmotic nephrosis in a renal transplant recipient. Kidney Int. 2006;70:1873–1876
  141. Standl T, Lipfert B, Reeker W, et al. [Acute effects of complete blood exchange with ultra-purified hemoglobin solution or hydroxyethyl starch on liver and kidney in the animal model]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1996;31:354–361
  142. Kief H, Engelbart K. [Reabsorptive vacuolization of the contorted main parts of the kidney (so-called osmotic nephrosis)]. Frankf Z Pathol. 1966;75:53–65
  143. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620–1622
  144. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248–249
  145. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis. Nephrol Dial Transplant. 1999;14:1517–1520
  146. Coronel B, Mercatello A, Colon S, et al. Hydroxyethyl starch and osmotic nephrosis-like lesions in kidney transplants. Lancet. 1996;348:1595
  147. Verhelst D, Moulin P, Haufroid V, et al. Acute renal injury following methanol poisoning: Analysis of a case series. Int J Toxicol. 2004;23:267–273
  148. Hamburger J, Halpern B, Funk-Brentano JL. Une varieté d’anuria provoquée par l’hydratation excessive des cellule renales. Nouv Presse. 1954;62:972–976
  149. Allen AC. The Kidney: Medical and Surgical Diseases. New York, NY: Grune & Stratton; 1962;
  150. Kief H, Engelbart K, Arnold G, et al. [Vacuolar reabsorption of native and digested gelatin (so-called osmotic nephrosis)]. Virchows Arch B Cell Pathol. 1968;1:240–250
  151. Kief H, Hajdu P, Engelbart K. [Reabsortive vacuolization (so-called osmotic nephrosis) following inulin]. Frankf Z Pathol. 1967;77:12–19
  152. Simon G, Chatelanat F, Falbriard A. Experimental nephrosis due to inulin: Light and electron microscopic studies. Lab Invest. 1964;13:1381–1393
  153. Lindberg HA, Wald MH, Barker MH. Renal changes following administration of hypertonic solutions. Arch Intern Med. 1939;63:907
  154. Träckner K. Experimentell Untersuchungen zur Frage der Peristonspeicherung in Mitochondrien der Nierentubuli. Zschr Ges Exp Med. 1954;123:101
  155. Ackermann RH. [Effects of parenteral infusion of glycerol on glycerol kinase and adenosine triphosphate in rat kidneys (author’s transl)]. Res Exp Med (Berl). 1975;166:251–263
  156. Schifferli J, Leski M, Favre H, et al. High-dose intravenous IgG treatment and renal function. Lancet. 1991;337:457–458
  157. Goodwin WE, Latta H. Focal osmotic nephrosis due to the therapeutic use of mannitol: A case of perirenal hematoma after renal biopsy. J Urol. 1970;103:11–14
  158. Dalgaard OZ, Pedersen KJ. Some observations of the fine structure of human kidney biopsies in acute anuria and osmotic diuresis. In:  Wolstenholme GW,  Cameron MP editor. Renal Biopsy. Boston, MA: Little Brown; 1962;p. 126–132
  159. Auquier L, Paolaggi JB, Rouques C, et al. [Fatal anuria after perfusion of low molecular weight dextran]. Therapie. 1968;23:751–754
  160. Fournier A, Watchi JM, Reveillaud RJ. [So-called osmotic nephrosis or hydropic vacuolization in the proximal tubules]. Presse Med. 1969;77:1987–1990
  161. Evans WA, Wong D. Renal changes following the administration of low molecular weight dextran. Aust N Z J Surg. 1966;36:69–73
  162. Favre H, Giromini M, Gerster JC, et al. [Anuria associated with low molecular dextran administration]. Schweiz Med Wochenschr. 1968;98:1982–1984
  163. Lamotte M, Roujeau J, Segrestaa JM, et al. [A case of anuria from osmotic nephropathy after perfusions of low molecular weight dextran]. Sem Hop. 1968;44:187–190
  164. Cayco AV, Perazella MA, Hayslett JP. Renal insufficiency after intravenous immune globulin therapy: A report of two cases and an analysis of the literature. J Am Soc Nephrol. 1997;8:1788–1794

 Originally published online as doi:10.1053/j.ajkd.2007.10.044 on February 1, 2008.

PII: S0272-6386(07)01592-2

doi: 10.1053/j.ajkd.2007.10.044

American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 491-503 , March 2008

Article Tools

* Image Usage & Resolution